Study of a special filter for septic shock patients
Part of Infections clinical trials.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have septic shock, meaning your blood pressure is low despite fluids and you need medication to keep it up.
- You are on a type of kidney replacement therapy (CVVH) with the Oxiris filter for at least 24 hours.
- You are over 18 years old.
- You are not pregnant.
- You do not have any condition that makes citrate (used to prevent clotting) unsafe for you.
- You are not expected to pass away within 24 hours from other serious illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special blood-filtering treatment (called Oxiris) for people with septic shock, a life-threatening condition where infection causes very low blood pressure. The goal is to see if this treatment can safely improve recovery. If you are already receiving CRRT, this may help your blood get cleaner and your pressure more stable.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
This study tests whether using a special filter (oXiris) during dialysis can better remove harmful toxins from the blood in people with septic shock and kidney failure, potentially helping them recover faster.
This trial tests a special blood filtering device (OXiris) in patients with severe abdominal infections and septic shock. The filter may help remove harmful substances from the blood and support kidney function, potentially improving recovery.
This trial tests a blood-filtering treatment for people in septic shock, a severe reaction to infection. It aims to see if removing harmful substances from the blood can help recovery.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.